Changes in Clinical Manifestations and Course of Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome over Three Decades

Systemic lupus erythematosus (SLE) is often associated with antiphospholipid syndrome (APS), which potentially results in a more severe disease course and reduced life expectancy. Since the therapeutic guidelines have been refined in the last 15 years, we assumed that the diseases course has become...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagy, Nikolett, Papp, Gábor, Gáspár-Kiss, Eszter, Diószegi, Ágnes, Tarr, Tünde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136176/
https://www.ncbi.nlm.nih.gov/pubmed/37189836
http://dx.doi.org/10.3390/biomedicines11041218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136176/
https://www.ncbi.nlm.nih.gov/pubmed/37189836
http://dx.doi.org/10.3390/biomedicines11041218

Ejemplares similares